Can You Reliably Tell a Skin Cancer Just by Looking at It?
Not always. And that is exactly why skin lesions deserve proper assessment.
Skin cancer does not always announce itself dramatically. Some lesions are obvious. Others are subtle, slow-changing, pale, pink, scaly, bleeding, pearly, pigmented, or simply different from the patient’s usual pattern. The danger lies in false reassurance — especially when advice is given by someone without the training, tools or clinical experience to recognise what may be significant.
In this educational video, Professor Ernest Azzopardi explains why skin assessment is not just about “having a look”. Safe diagnosis depends on experience, pattern recognition, dermoscopy where appropriate, clinical judgement, and — when indicated — biopsy or histological confirmation.
This is not about alarming patients. It is about taking skin changes seriously.
If a mole, mark, ulcer, lump or patch is new, changing, bleeding, not healing, becoming irregular, or simply worrying you, it should be assessed by an appropriately trained medical professional. Early recognition matters. So does knowing when something apparently small should not be dismissed.
At SkinSurgeon®, our approach combines specialist surgical assessment, skin cancer experience and modern imaging-supported practice, with a clear aim: to give patients informed, responsible and clinically grounded advice.
A photograph, a casual opinion or a quick glance is not a diagnosis.
When it comes to skin cancer, uncertainty should be respected — not ignored.
Bad Botox: When Aesthetic Treatment Becomes a Patient Safety Issue
Botulinum toxin is often presented as a quick, simple and routine cosmetic treatment. In properly trained hands, using licensed products and appropriate clinical judgement, it can be safe and effective. But when injectable treatments are performed by individuals without recognised qualifications — or with products that are not licensed for patient use — the risk profile changes completely.This video discusses the dangers of poor practice in aesthetic medicine, including cases where treatments are reportedly carried out by unqualified individuals using research-grade botulinum toxin. Research-grade products are not intended for clinical treatment. They do not belong in cosmetic practice, and their use on patients raises serious concerns around safety, sterility, dosing, storage, traceability and accountability.The issue is not botulinum toxin itself. The issue is unsafe practice.Patients should feel empowered to ask direct questions before treatment: who is injecting me, what qualifications do they hold, what product is being used, is it licensed, where was it sourced from, and what happens if there is a complication?Aesthetic medicine should never be reduced to price alone. A cheap treatment can become very expensive when complications occur.
Botulism can kill.
Natural results matter, but safety, training, product integrity and clinical accountability matter even more. Before allowing anyone to inject your face, ask one simple question:If something goes wrong, are they qualified to manage it?
Does Sunblock Cause Skin Cancer?
Does sunblock cause skin cancer? The short answer is no — but the truth is more nuanced than the myth. In this video, Professor Ernest Azzopardi explores the relationship between sun protection, vitamin D, and melanoma outcomes. While excessive ultraviolet exposure remains a major preventable risk factor for skin cancer, emerging evidence also suggests that vitamin D deficiency may be associated with poorer outcomes in melanoma.
The message is not to abandon sun protection, but to use it intelligently — protecting the skin while recognising, testing and correcting vitamin D deficiency where appropriate